J.-L. Jagot

550 total citations
8 papers, 374 citations indexed

About

J.-L. Jagot is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, J.-L. Jagot has authored 8 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in J.-L. Jagot's work include Pulmonary Hypertension Research and Treatments (3 papers), Multiple and Secondary Primary Cancers (2 papers) and Vascular Anomalies and Treatments (2 papers). J.-L. Jagot is often cited by papers focused on Pulmonary Hypertension Research and Treatments (3 papers), Multiple and Secondary Primary Cancers (2 papers) and Vascular Anomalies and Treatments (2 papers). J.-L. Jagot collaborates with scholars based in France and Japan. J.-L. Jagot's co-authors include Olivier Sitbon, Gérald Simonneau, Marc Humbert, Muriel Fartoukh, Florence Parent, Philippe Hervé, Olivier Sanchez, C. Gall, E Habib and R. Sartène and has published in prestigious journals such as CHEST Journal, European Respiratory Journal and Revue des Maladies Respiratoires.

In The Last Decade

J.-L. Jagot

8 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J.-L. Jagot France	4	354	216	79	51	41	8	374
A. Mañes Italy	2	497 1.4×	364 1.7×	119 1.5×	48 0.9×	17 0.4×	2	518
Michela Efficace Switzerland	5	440 1.2×	368 1.7×	66 0.8×	50 1.0×	34 0.8×	11	487
LJ Rubin United States	2	626 1.8×	436 2.0×	122 1.5×	66 1.3×	37 0.9×	6	653
J. Lemarié France	6	253 0.7×	195 0.9×	54 0.7×	29 0.6×	13 0.3×	11	278
Martha Kingman United States	9	262 0.7×	194 0.9×	41 0.5×	24 0.5×	21 0.5×	21	305
Mobeen Iqbal United States	10	401 1.1×	107 0.5×	54 0.7×	11 0.2×	67 1.6×	12	511
Sylvia Nikkho Germany	14	559 1.6×	358 1.7×	93 1.2×	47 0.9×	65 1.6×	33	622
Juliana Liu United States	4	417 1.2×	176 0.8×	83 1.1×	22 0.4×	22 0.5×	7	472
Rubina Khair United States	7	276 0.8×	165 0.8×	48 0.6×	24 0.5×	18 0.4×	10	318
Paul Sephton United Kingdom	3	353 1.0×	212 1.0×	70 0.9×	23 0.5×	15 0.4×	7	362

Countries citing papers authored by J.-L. Jagot

Since Specialization

Citations

This map shows the geographic impact of J.-L. Jagot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-L. Jagot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-L. Jagot more than expected).

Fields of papers citing papers by J.-L. Jagot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.-L. Jagot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-L. Jagot. The network helps show where J.-L. Jagot may publish in the future.

Co-authorship network of co-authors of J.-L. Jagot

This figure shows the co-authorship network connecting the top 25 collaborators of J.-L. Jagot. A scholar is included among the top collaborators of J.-L. Jagot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.-L. Jagot. J.-L. Jagot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Bigot, Frédéric, Loïc Verlingue, Stéphane Jouveshomme, et al.. (2013). Évolution épidémiologique du cancer broncho-pulmonaire en France et en Europe. Revue des Maladies Respiratoires Actualités. 5(5). 321–324. 1 indexed citations

2.

Teixeira, Luís, Emmanuelle Kempf, Stéphane Jouveshomme, et al.. (2012). Place des traitements ciblés dans la prise en charge des cancers broncho-pulmonaires. Pathologie Biologie. 60(4). 246–253. 1 indexed citations

3.

Choudat, Laurence, et al.. (2006). Épidémiologie et délais de prise en charge de 355 patients atteints de cancer bronchique. Revue des Maladies Respiratoires. 23(1). 43–48. 20 indexed citations

4.

Jagot, J.-L., et al.. (2004). Nocardiose pulmonaire et fistule broncho-œsophagienne chez un patient infecté par le VIH. Revue des Maladies Respiratoires. 21(1). 147–151. 2 indexed citations

5.

Jagot, J.-L., et al.. (2003). [Home chemotherapy for lung cancer: a five year retrospective study].. PubMed. 20(5 Pt 1). 683–9. 3 indexed citations

6.

Humbert, Marc, Olivier Sanchez, Muriel Fartoukh, et al.. (1999). Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study. European Respiratory Journal. 13(6). 1351–1356. 92 indexed citations

7.

Sitbon, Olivier, Marc Humbert, J.-L. Jagot, et al.. (1998). Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension. European Respiratory Journal. 12(2). 265–270. 217 indexed citations

8.

Humbert, Marc, Olivier Sanchez, Muriel Fartoukh, et al.. (1998). Treatment of Severe Pulmonary Hypertension Secondary to Connective Tissue Diseases With Continuous IV Epoprostenol (Prostacyclin). CHEST Journal. 114(1). 80S–82S. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact